Status:
COMPLETED
Sugammadex Dosing: Anaesthesiologist Clinical Perception Versus Quantitative Monitoring
Lead Sponsor:
Hospital do Divino Espírito Santo de Ponta Delgada
Conditions:
Neuromuscular Blockade
Anesthesia
Eligibility:
All Genders
18-75 years
Brief Summary
Many clinicians continue to rely on subjective evaluation in making decisions about the adequacy of neuromuscular function before tracheal extubation rather than using quantitative monitoring. The aim...
Detailed Description
Materials and Methods: After obtaining approval from the Institute Ethics Committee, a prospective 3-month study in patients aged 18-75 years who underwent general anesthesia with rocuronium (initial...
Eligibility Criteria
Inclusion
- Patients aged 18-75 years;
- Above patients who underwent general anesthesia with rocuronium neuromuscular blockade and subsequent reversal with sugammadex.
Exclusion
- American Society of Anesthesiologists physical status V;
- Emergency surgery;
- Hypersensitivity history to rocuronium or sugammadex;
- Severe renal impairment/dialysis;
- Neuromuscular diseases;
- Severe hepatic disease;
- Pre-existing coagulopathies;
- Pregnancy.
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2019
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04762420
Start Date
February 1 2019
End Date
April 30 2019
Last Update
February 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital do Divino Espírito Santo
Ponta Delgada, Portugal, 9500-370